Skip to content
Tirzepatide Report

Understand tirzepatide. Compare your options.

Clear answers about treatment, costs and prescription care, backed by research and official sources.

Compare providersResearch evidence

Compare prescription care

Published prices, medication options and the details to confirm before enrolling.

See the full comparison

Advertising disclosure: affiliate partners appear first; placement is not an independent quality score. We may earn a commission through partner links, at no extra cost to you.

Featured sponsor

CoreAge Rx

From $129/mo; term varies

Compounded tirzepatide

  • No separate membership fee advertised
  • Product page includes delivery and clinician assessment
Check availability Read review

We may earn a commission through this link. Disclosure

Another option

Found

$359/4 weeks cash; $219 intro

Compounded tirzepatide and brand-name GLP-1 options

  • Medication-specific offer table separates cash and insured rates
  • Care and medication bundled on compounded plans
Check availability Read review

We may earn a commission through this link. Disclosure

Another option

Gala Health

$179/mo (yearly plan)

Compounded GLP-1/GIP incl. tirzepatide (brand Ozempic available separately)

  • Low compounded entry at $179/month with all doses included, so titrating up costs nothing extra
  • Available in all 50 states — broader coverage than most compounded-only startups
Check availability Read review

We may earn a commission through this link. Disclosure

New evidence, clearly explained.

Explore the research library
Approval update

What Mounjaro’s cardiovascular approval actually covers

Mounjaro’s 2026 label adds cardiovascular risk reduction for certain adults with type 2 diabetes. Who qualifies—and why this is not a Zepbound indication.

Read the evidence Maintenance

Can a lower dose help maintain weight loss?

SURMOUNT-MAINTAIN compared 5 mg, continued maximum dosing and stopping tirzepatide after weight loss. What the results mean for maintenance decisions.

Read the evidence Developing research

The new muscle-preservation study, in perspective

The 2026 EMBRAZE trial tested an investigational muscle-preserving treatment with tirzepatide. Understand the results, limits and practical implications.

Read the evidence Other conditions

What the latest IBD comparison can—and cannot—tell us

A new observational study examined tirzepatide in inflammatory bowel disease. What it suggests, what it cannot prove and what to discuss with your GI team.

Read the evidence

Put the numbers in context

Free calculators for practical questions. Estimates and arithmetic, not treatment advice.

All calculators and tools

Estimate Zepbound costs

Compare vial and pen prices, insurance routes and membership fees. See the assumptions behind the total.

Open tool

Convert mg and U-100 units

Use your prescribed dose and pharmacy-label concentration. This tool calculates volume; it does not choose a dose.

Open tool

Explore trial-based weight changes

Apply SURMOUNT-1 group averages to a starting weight. An illustration of trial data, not a personal prediction.

Open tool

The price index

See beyond the starting price.

Compare the numbers behind published program prices. Brand and compounded products are different; compounded tirzepatide is not FDA-approved.

Dataset updated October 2026

Median published compounded price
$279/mo

Among tracked programs with a confirmable price.

Lowest tracked flat monthly price
$109/mo

Lean Meds; confirm eligibility and current terms.

Open the full price indexCheck pharmacy and verification details

Clinical research, official sources and clear commercial disclosures guide how we publish.